May 2024

With symptomatic and asymptomatic forms of peripheral arterial disease potentially leading to limb and life-threatening complications, a robust understanding and practical framework for addressing this disease are indispensable.

Transthyretin cardiac amyloidosis is an under-recognised cause of heart failure with preserved ejection fraction. Accurate diagnosis can avoid delayed treatment. New disease-modifying therapies are now available in Australia. Referral to a cardiologist or specialised amyloidosis clinic is crucial for patients who are suspected of having amyloidosis.